Traws Pharma (TRAW) Current Deferred Revenue (2012 - 2025)
Traws Pharma (TRAW) posted Current Deferred Revenue of $226,000 for Q1 2025, unchanged from $226,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Traws Pharma (TRAW) Current Deferred Revenue (2012 - 2025) Analysis & Trends
Since Q4 2012, Traws Pharma has reported Current Deferred Revenue for 49 quarters.
- Annual Current Deferred Revenue shows a five-year compound annual growth rate of 0.0% (FY2019 to FY2024).
- In prior years, Traws Pharma's Current Deferred Revenue was $226,000 in FY2023 (unchanged), $226,000 in FY2022 (unchanged), $226,000 in FY2021 (unchanged) and $226,000 in FY2020 (unchanged).
- Quarterly Current Deferred Revenue has run from a low of $226,000 in Q2 2020 to a high of $227,000 in Q2 2024 over five years.
- On a year-over-year basis, Current Deferred Revenue increased in 1 of the last eight quarters, with growth averaging 0.1%.
- According to Business Quant data, Current Deferred Revenue for the three prior quarters was $226,000 (Q4 2024), $226,000 (Q3 2024) and $227,000 (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Traws Pharma | 6.00 Mn | -12.39 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 226,000.00 |
| Dec 31, 2024 | 226,000.00 |
| Sep 30, 2024 | 226,000.00 |
| Jun 30, 2024 | 227,000.00 |
| Mar 31, 2024 | 226,000.00 |
| Dec 31, 2023 | 226,000.00 |
| Sep 30, 2023 | 226,000.00 |
| Jun 30, 2023 | 226,000.00 |
| Mar 31, 2023 | 226,000.00 |
| Dec 31, 2022 | 226,000.00 |
| Sep 30, 2022 | 226,000.00 |
| Jun 30, 2022 | 226,000.00 |
| Mar 31, 2022 | 226,000.00 |
| Dec 31, 2021 | 226,000.00 |
| Sep 30, 2021 | 226,000.00 |
| Jun 30, 2021 | 226,000.00 |
| Mar 31, 2021 | 226,000.00 |
| Dec 31, 2020 | 226,000.00 |
| Sep 30, 2020 | 226,000.00 |
| Jun 30, 2020 | 226,000.00 |
API Access
Traws Pharma Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=TRAW&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "TRAW", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=TRAW&period=max&api_key=YOUR_API_KEY");
const data = await res.json();